Should liver biopsy be systematic during surgery for ulcerative colitis?;Faut-il réaliser une biopsie hépatique per-opératoire systématique chez tous les malades opérés pour rectocolite hémorragique?

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 1, 2003, Pages 94-99

  Scalone, Olivia ^a,b   Bonaventure, Cyril ^a   Pasquier, Dominique ^a   Faucheron, Jean Luc ^a  

^a HÔPITAL MICHALLON   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHOLANGITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER BIOPSY; MALE; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PROCTOCOLECTOMY; STEATOSIS; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; BIOPSY; CHOLANGITIS; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PROCTOCOLECTOMY, RESTORATIVE; REOPERATION; TIME FACTORS;

EID: 0037279946     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Guyader D, Deugnier P, Brissot P. Cholangite sclérosante primitive. Gastroenterol Clin Biol 1990;104:850-60.
2. Mir-Madjlessi SH, Farmer RG, Sivak MV Jr. Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: report of six cases and review of the literature. Dig Dis Sci 1987;32:145-54.
3. Angulo P, Maor-Kendler Y, Lindor KD. Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 2002;35:1494-500.
4. Rasmussen HH, Fallingsborg J, Mortensen PB, Freund L, Tage-Jensen U, Kruse V, et al. Primary sclerosing cholangitis in patients with ulcerative colitis. Scand J Gastroenterol 1992;27:732-6.
5. Balasubramaniam K, Wiesner RH, LaRusso NF. Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 1988;95:1395-8.
6. Wee A, Ludwig J. Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 1985;102:581-7.
7. Schrumpf E, Abdelnoor M, Fausa O, Elgjon K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol 1994;21:1061-6.
8. Broome U, Olsson R, Loof L, Bodemar B, Hultcrzantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38:610-5.
9. Schrumpf E, Fausa O, Kolmannskog F, Elgjon K, Ritland S, Gjone E. Sclerosing cholangitis in ulcerative colitis. A follow-up study. Scand J Gastroenterol 1982;17:33-9.
10. Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319-23.
11. Wiesner RH, LaRusso NF. Clinicopathological features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79:200-6.
12. Bergquist A, Ekbom A, Olsson R, Komfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321-7.
13. Broome U, Lindberg G, Lofberg R. Primary sclerosing cholangitis in ulcerative colitis: a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 1992;102:1877-80.
14. Gurbuz AK, Giardiello FM, Bayless TM. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 1995;38:37-41.
15. Bjomsson E, Boberg KM, Cullen S, Fleming K, Clausen OP, Fausa O, et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut 2002;51:731-5.
16. Mitchell SA, Bansi DS, Hunt N, Von Bergmann K, Fleming KA, Chapman RW. A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 2001;121:900-7.